Maryland State Retirement & Pension System’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Maryland State Retirement & Pension System’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14,956	Closed	-$1.38M	–	1015
2021 Q1	$1.38M	Buy	14,956 +11,800	+374%	+$996K	0.05%	376
2020 Q4	$230K	Buy	+3,156	New	+$235K	0.04%	429

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Maryland State Retirement & Pension System's HZNP Position: Q2 2021 in Review

Maryland State Retirement & Pension System sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2021, closing a stake of 14,956 shares — an estimated $1.38M sold.

Maryland State Retirement & Pension System first reported a position in HZNP in Q4 2020 and held it in 2 quarters. The position peaked at $1.38M in Q1 2021. 526 funds tracked by Wall St. Rank hold HZNP as of Q2 2021.

Maryland State Retirement & Pension System reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2021 after selling out during the quarter.
Maryland State Retirement & Pension System sold 14,956 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2021, an estimated $1.38M.
Maryland State Retirement & Pension System first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 2 quarters.
Maryland State Retirement & Pension System's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.38M in Q1 2021.
526 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2021.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2021, filed 13 Jul 2021.